Literature DB >> 9662397

BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A.

S F Anderson1, B P Schlegel, T Nakajima, E S Wolpin, J D Parvin.   

Abstract

The breast cancer specific tumour suppressor protein, BRCA1 (refs 1,2), activates transcription when linked with a DNA-binding domain and is a component of the RNA polymerase II (Pol II) holoenzyme. We show here that RNA helicase A (RHA) protein links BRCA1 to the holoenzyme complex. The region of BRCA1 which interacts with RHA and, thus, the holoenzyme complex, corresponds to subregions of the BRCT domain of BRCA1 (ref. 9). This interaction was shown to occur in yeast nuclei, and expression in human cells of a truncated RHA molecule which retains binding to BRCA1 inhibited transcriptional activation mediated by the BRCA1 carboxy terminus. These data are the first to identify a specific protein interaction with the BRCA1 C-terminal domain and are consistent with the model that BRCA1 functions as a transcriptional coactivator.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9662397     DOI: 10.1038/930

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  121 in total

1.  BRCA1 can stimulate gene transcription by a unique mechanism.

Authors:  G Nadeau; N Boufaied; A Moisan; K M Lemieux; C Cayanan; A N Monteiro; L Gaudreau
Journal:  EMBO Rep       Date:  2000-09       Impact factor: 8.807

2.  BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site.

Authors:  H Ruffner; W Jiang; A G Craig; T Hunter; I M Verma
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

3.  BRCA1 interacts with components of the histone deacetylase complex.

Authors:  R I Yarden; L C Brody
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

4.  BRCA1 at a branch point.

Authors:  J D Parvin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

5.  Coordination of editing and splicing of glutamate receptor pre-mRNA.

Authors:  Eva Bratt; Marie Ohman
Journal:  RNA       Date:  2003-03       Impact factor: 4.942

6.  A DHX9-lncRNA-MDM2 interaction regulates cell invasion and angiogenesis of cervical cancer.

Authors:  Xiangya Ding; Xuemei Jia; Cong Wang; Jingyun Xu; Shou-Jiang Gao; Chun Lu
Journal:  Cell Death Differ       Date:  2018-12-05       Impact factor: 15.828

7.  Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci.

Authors:  L J Huber; T W Yang; C J Sarkisian; S R Master; C X Deng; L A Chodosh
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

8.  Chromatin configuration and epigenetic landscape at the sex chromosome bivalent during equine spermatogenesis.

Authors:  Claudia Baumann; Christopher M Daly; Sue M McDonnell; Maria M Viveiros; Rabindranath De La Fuente
Journal:  Chromosoma       Date:  2011-01-28       Impact factor: 4.316

9.  CBP/p300 interact with and function as transcriptional coactivators of BRCA1.

Authors:  G M Pao; R Janknecht; H Ruffner; T Hunter; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

10.  Mitochondrial localization, ELK-1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins.

Authors:  Anna W Maniccia; Catherine Lewis; Nurjahan Begum; Jingyao Xu; Jianqi Cui; Galina Chipitsyna; Kartik Aysola; Vaishali Reddy; Ganapathy Bhat; Yasuo Fujimura; Beric Henderson; E Shyam P Reddy; Veena N Rao
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.